Skip to main content
Clinical Trials/NCT02286908
NCT02286908RecruitingNot Applicable

Improved Prediction of Clinical Outcome With the Use of Global Strain and Mechanical Dispersion in Patients With Myocardial Infarction and Heart Failure

Oslo University Hospital8 sites in 2 countries3,100 target enrollmentStarted: June 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
3,100
Locations
8
Primary Endpoint
Ventricular arrhythmia and death after acute myocardial infarction or heart failure.

Study Overview

Brief Summary

The aim of the study is to investigate if global strain and mechanical dispersion may predict death and ventricular arrhythmias better than ejection fraction(EF) in patients with myocardial infarction and heart failure regardless of cause.

Detailed Description

  1. The main aim of this study is to investigate if global strain and mechanical dispersion may predict death and ventricular arrhythmias better than left ventricular ejection fraction in patients with myocardial infarction and heart failure.
  2. In patients who receive internal cardioverter defibrillator(ICD) the main aim is to investigate if mechanical dispersion may predict ventricular arrhythmias better than EF.
  1. No interventions,only evaluation of the measurements obtained with transthoracic echocardiography.

  2. Follow up for 3 years, extended from 3 to 5 years.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients with
  • •myocardial infarction
  • •heart failure( defined as heart failure symptoms: reduced left ventricular function/ and or heart failure signs on chest x ray.
  • •planned for primary prophylactic ICD
  • •over 18 years of age
  • •Informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Ventricular arrhythmia and death after acute myocardial infarction or heart failure.

Time Frame: 5 years or more

Arrhythmic events during follow-up are defined as documented sustained ventricular tachycardia, ventricular fibrillation, and SCD. Survival is assessed by medical charts if patients are within the uptake area of the hospital and by the Norwegian death registry Folkeregisteret.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Oslo University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thor Edvardsen

Professor, Chief department of Cardiology Oslo university hospital

Oslo University Hospital

Study Sites (8)

Loading locations...

Similar Trials